1104 related articles for article (PubMed ID: 10570211)
21. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries.
Chataigneau T; Félétou M; Thollon C; Villeneuve N; Vilaine JP; Duhault J; Vanhoutte PM
Br J Pharmacol; 1998 Mar; 123(5):968-74. PubMed ID: 9535027
[TBL] [Abstract][Full Text] [Related]
22. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
[TBL] [Abstract][Full Text] [Related]
23. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
[TBL] [Abstract][Full Text] [Related]
24. An endogenous cannabinoid as an endothelium-derived vasorelaxant.
Randall MD; Alexander SP; Bennett T; Boyd EA; Fry JR; Gardiner SM; Kemp PA; McCulloch AI; Kendall DA
Biochem Biophys Res Commun; 1996 Dec; 229(1):114-20. PubMed ID: 8954092
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
26. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.
Varga K; Wagner JA; Bridgen DT; Kunos G
FASEB J; 1998 Aug; 12(11):1035-44. PubMed ID: 9707176
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
[TBL] [Abstract][Full Text] [Related]
28. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
Ho WS; Hiley CR
J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
[TBL] [Abstract][Full Text] [Related]
29. Involvement of CB1 cannabinoid receptors in the EDHF-dependent vasorelaxation in rabbits.
Niederhoffer N; Szabo B
Br J Pharmacol; 1999 Mar; 126(6):1383-6. PubMed ID: 10217532
[TBL] [Abstract][Full Text] [Related]
30. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
31. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
Ishioka N; Bukoski RD
J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
[TBL] [Abstract][Full Text] [Related]
32. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Cardiovasc Res; 2015 Sep; 107(4):568-78. PubMed ID: 26092099
[TBL] [Abstract][Full Text] [Related]
33. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
34. The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.
Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
Pharmacol Res; 2016 Nov; 113(Pt A):356-363. PubMed ID: 27633407
[TBL] [Abstract][Full Text] [Related]
35. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
Paria BC; Ma W; Andrenyak DM; Schmid PC; Schmid HH; Moody DE; Deng H; Makriyannis A; Dey SK
Biol Reprod; 1998 Jun; 58(6):1490-5. PubMed ID: 9623610
[TBL] [Abstract][Full Text] [Related]
36. Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.
Lobato NS; Filgueira FP; Prakash R; Giachini FR; Ergul A; Carvalho MH; Webb RC; Tostes RC; Fortes ZB
PLoS One; 2013; 8(5):e63449. PubMed ID: 23667622
[TBL] [Abstract][Full Text] [Related]
37. Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed.
Harris D; McCulloch AI; Kendall DA; Randall MD
J Physiol; 2002 Mar; 539(Pt 3):893-902. PubMed ID: 11897858
[TBL] [Abstract][Full Text] [Related]
38. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
[TBL] [Abstract][Full Text] [Related]
39. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation.
Randall MD; Kendall DA
Eur J Pharmacol; 1997 Sep; 335(2-3):205-9. PubMed ID: 9369375
[TBL] [Abstract][Full Text] [Related]
40. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
